Add-on astragalus in type 2 diabetes and chronic kidney disease: A multi-center, assessor-blind, randomized controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Add-on astragalus in type 2 diabetes and chronic kidney disease: A multi-center, assessor-blind, randomized controlled trial

Published:2024-07 Issue: Volume:130 Page:155457
ISSN:0944-7113
Container-title:Phytomedicine
language:en
Short-container-title:Phytomedicine

Author:

Chan Kam Wa^ORCID,Kwong Alfred Siu Kei,Tsui Pun Nang,Chan Gary Chi Wang^ORCID,Choi Wing Fai,Yiu Wai Han,Cheung Simon Chi Yuen,Wong Michelle Man Ying,Zhang Zhang-Jin,Tan Kathryn Choon Beng^ORCID,Lao Lixing,Lai Kar Neng,Tang Sydney Chi Wai^ORCID

Funder

University of Hong Kong

China Medical Board

Health and Medical Research Fund

Publisher

Elsevier BV

Reference46 articles.

1. Integrative Management For Diabetic Kidney Disease – patients’ and clinicians’ perspectives, Clinical Effectiveness and Possible Mechanisms [PhD Thesis];Chan,2018

2. Effectiveness of integrative Chinese-western medicine for chronic kidney disease and diabetes: a retrospective cohort study;Chan;Am. J. Chin. Med.,2022

3. SYmptom-based stratification of diabetes mellitus by renal function (SYSTEM): a retrospective cohort study and modelling assessment;Chan;Front. Med.,2021

4. Add-on rehmannia-6-based Chinese medicine in type 2 diabetes and CKD: a multicenter randomized controlled trial;Chan;Clin. J. Am. Soc. Nephrol.,2023

5. Efficacy, safety and response predictors of adjuvant astragalus for diabetic kidney disease (READY): study protocol of an add-on, assessor-blind, parallel, pragmatic randomised controlled trial;Chan;B.M.J Open,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP